SKERLJ RENATO (Chief Scientific Officer) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 8/18/2020ACC: 0001628280-20-012844
Officer· Chief Scientific Officer
Since Jun 2020
+17.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
17.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.75K
Price / share
—
Trade value
—
% of position
28.8%
8/14/2020
30.41K→39.16K
Common Stock
Direct
Shares
+8.75K
Price / share
—
Trade value
—
% of position
22.3%
8/17/2020
39.16K→47.91K
Total
Net shares
+17.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2020 | A · Award | +8.75K | — | — | 28.8% | 30.41K | 39.16K |
| Common Stock Direct | 8/17/2020 | A · Award | +8.75K | — | — | 22.3% | 39.16K | 47.91K |
| Total | +17.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported